Sectors

RLYB
Rallybio Corporation
16.68
1 x 16.55
40 x 16.99
bid
ask
-
0.23
1.33%
09:57 AM
timesize
Ytd203.92%
1y326.73%
16.53
day range
16.93
3.20
52 week range
17.57
Open16.93Prev Close16.91Low16.53High16.93Mkt Cap89.74M
Vol2.92KAvg Vol247.34KEPS-2.93P/E-5.77Forward P/E-0.72
Beta-0.90Short Ratio5.26Inst. Own76.27%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0750-d Avg15.56200-d Avg8.821yr Est8.25
Income Statement
Total Revenue212.00K
Revenues (USD)212.00K
Gross Profit212.00K
Operating Expenses8.95M
Research and Development Expense2.87M
Selling, General and Administrative Expense6.07M
Operating Income-8.73M
Net Income-8.28M
Net Income Common Stock-8.28M
Net Income Common Stock (USD)-8.28M
Consolidated Income-8.28M
Earnings per Basic Share-1.46
Earnings per Basic Share (USD)-1.46
Earnings per Diluted Share-1.46
Earning Before Interest & Taxes (EBIT)-8.28M
Earning Before Interest & Taxes (USD)-8.28M
Weighted Average Shares5.69M
Weighted Average Shares Diluted5.69M
Balance Sheet
Cash and Equivalents41.30M
Cash and Equivalents (USD)41.30M
Investments5.50M
Investments Current5.50M
Current Assets53.49M
Property, Plant & Equipment Net172.00K
Total Assets54.47M
Debt Current99.00K
Total Debt154.00K
Current Liabilities4.14M
Debt Non-Current55.00K
Total Liabilities4.20M
Accumulated Retained Earnings (Deficit)-310.28M
Accumulated Other Comprehensive Income1000
Shareholders Equity50.28M
Shareholders Equity (USD)50.28M
Assets Non-Current982.00K
Total Debt (USD)154.00K
Liabilities Non-Current55.00K
Trade and Non-Trade Payables940.00K
Cash Flow
Depreciation, Amortization & Accretion3.00K
Net Cash Flow from Financing3.00K
Net Cash Flow / Change in Cash & Cash Equivalents9.93M
Issuance (Purchase) of Equity Shares3.00K
Net Cash Flow from Investing17.90M
Net Cash Flow - Investment Acquisitions and Disposals17.90M
Net Cash Flow from Operations-7.98M
Share Based Compensation613.00K